Determination of associated antimicrobial resistance in clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa in a public hospital in Goiania, State of Goias

被引:6
作者
Branco Artiaga Kobayashi, Claudia Castelo [2 ]
Sadoyama, Geraldo
Goncalves Vieira, Jose Daniel [1 ]
机构
[1] Univ Fed Goias, IPTSP, Bacteriol Lab, Setor Univ, BR-74605050 Goiania, Go, Brazil
[2] Hosp Urgencias Goiania, Goiania, Go, Brazil
关键词
Staphylococcus aureus; Pseudomonas aeruginosa; Associated antimicrobial resistance; METHICILLIN-RESISTANT; ESCHERICHIA-COLI; CROSS-RESISTANCE; RISK-FACTORS; BACTERIA; OUTCOMES; SUSCEPTIBILITY; ACQUISITION; AGENTS;
D O I
10.1590/S0037-86822009000400009
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
This study evaluated the associated antimicrobial resistance of Pseudomonas aeruginosa and Staphylococcus aureus in relation to an antimicrobial agent with other drugs. The associated antimicrobial resistance was calculated by means of the relative risk. There was an obvious relationship between oxacillin resistance and resistance to other antimicrobial agents among isolates of oxacillin-resistant Staphylococcus aureus (68.5%), greater than 32%, except for linezolid (6.7%). Pronounced associated resistance among drugs was observed for Pseudomonas aeruginosa isolates, particularly for ciprofloxacin and carbapenems (59.6% to 60.7%) and for aminoglycosides and carbapenems (66.3% to 67.7%) and other lactam antibiotics (52.3% to 85.8%). The present study emphasizes the importance of diagnostic cultures and susceptibility testing for selecting the correct antimicrobial agent, with regard to the clinical impact of increased multiresistance and selection of associated antimicrobial resistance.
引用
收藏
页码:404 / 410
页数:7
相关论文
共 31 条
[1]   Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact [J].
Aloush, V ;
Navon-Venezia, S ;
Seigman-Igra, Y ;
Cabili, S ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :43-48
[2]   Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime [J].
Alyaseen, SA ;
Piper, KE ;
Rouse, MS ;
Steckelberg, JM ;
Patel, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2543-2545
[3]  
Bernardes RC, 2004, REV BIOCIENCIAS, V10, P73
[4]  
*CLIN LAB STAND I, 2007, M100S17 CLIN LAB STA, V27, P1
[5]   Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection [J].
Engemann, JJ ;
Carmeli, Y ;
Cosgrove, SE ;
Fowler, VG ;
Bronstein, MZ ;
Trivette, SL ;
Briggs, JP ;
Sexton, DJ ;
Kaye, KS .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :592-598
[6]  
Figueiredo Eduardo Andrada Pessoa de, 2007, Rev. bras. ter. intensiva, V19, P421, DOI 10.1590/S0103-507X2007000400003
[7]   Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study [J].
Fluit, AC ;
Wielders, CLC ;
Verhoef, J ;
Schmitz, FJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3727-3732
[8]  
HERNANDEZ NMR, 2001, REV CUBA MED TROP, V53, P53
[9]   Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections [J].
Kahlmeter, G ;
Menday, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :128-131
[10]   In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea:: a nationwide survey [J].
Kim, HB ;
Jang, HC ;
Nam, HJ ;
Lee, YS ;
Kim, BS ;
Park, WB ;
Lee, KD ;
Choi, YJ ;
Park, SW ;
Oh, MD ;
Kim, EC ;
Choe, KW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1124-1127